CSI: Abbott Completes Acquisition of Cardiovascular Systems

Abbott (NYSE: ABT) completed the acquisition of Cardiovascular Systems, Inc., a medical device company with an innovative atherectomy system used in treating peripheral and coronary artery disease. The transaction provides Abbott with a complementary solution for treating vascular disease. CSI's atherectomy system prepares vessels for angioplasty or stenting to restore blood flow. Pursuant to the terms [...] The post Abbott Completes Acquisition of Cardiovascular Systems appeared first on FinSMEs.